2016 VAM: 2810 - Clinical Implications of Microbiome in Chronic Respiratory Disease
This session will discuss some of the limitations and caveats of the microbiome data, the relationship of the upper and lower respiratory tract between the host and microorganism on the microbiome and clinical implications.
AMA PRA Category 1 Credits™: 1.25
Credit must be claimed by May 31, 2018. Any credit request on or after June 1, 2018 will be subject to an administrative fee.
Allied Health Professionals
Upon completion of this activity, participants will be able to:
1. Discuss the deep sequencing technology, its limitations and consequences on the understanding of the microbiome, especially the limited understanding of the fungal microbiome
2. Identify current knowledge of airway microbiota and outline how host-microorganism interactions influence health and disease
3. Discuss how the microbiota in the mouth and nose influences the microorganism communities in the lungs and implications on disease
Dr. David B. Corry, MD, Baylor College of Medicine, Houston, TX
Dr. Yvonne Huang, MD, University of Michigan, Ann Arbor, MI
Prof. Gary Huffnagle, PhD, University of Michigan Medical School, Ann Arbor, MI
- 1.25 CECE credit.
- 1.25 CMECME credit.